Mr. Bansal joined Onconova in March, 2013. He is a biotechnology and pharmaceutical industry veteran with leadership experience spanning the areas of finance, hedge fund management, equity research, mergers and acquisitions, post-merger integration, strategic planning, licensing, sales and marketing. Before joining Onconova, Mr. Bansal served as. CFO of Complete Genomics, a publicly-traded life science company.. Prior to Complete Genomics, Mr. Bansal served as the CFO and EVP, Corporate and Business Development, at both Lexicon Therapeutics and Tercica, Inc. He also served as the CFO of Nektar Therapeutics from 2003-2006.. Before his experiences as a biotechnology executive, he was a partner at Mehta Partners, LLC. Earlier in his career, Mr. Bansal worked in strategy and marketing for Novartis Pharmaceuticals and held positions with leading consulting firms, such as McKinsey & Company. He received master’s degrees in both management and operations research from Northwestern University.
